Abstract
IntroductionSodium-glucose co-transporter 2 inhibitors (SGLT-2i) increase urinary glucose excretion through a reduced renal glucose reabsorption. We plan to perform a systematic review of SGLT-2i for treatment of type 2 diabetes.Methods...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have